| 000 | 01175nam a2200241Ia 4500 | ||
|---|---|---|---|
| 003 | MX-MdCICY | ||
| 005 | 20250625153926.0 | ||
| 040 | _cCICY | ||
| 090 | _aB-13622 | ||
| 245 | 1 | 0 | _aNew approaches to the treatment of giardiasis |
| 490 | 0 | _vCurr Opin Infect Dis, 24(5), p.451-456, 2011 | |
| 520 | 3 | _aThe pipeline of new antigiardial drug candidates has significantly expanded over the last few years, but this expansion has so far not been accompanied by demonstration of efficacy in animal models or by a clear understanding of the action mechanisms, particularly in regard to new nitro antimicrobials. Many challenges are still to be expected before clinical utility of new antigiardial drugs can be established. | |
| 650 | 1 | 4 | _aANTIMICROBIALS |
| 650 | 1 | 4 | _aDIARRHEAL DISEASE |
| 650 | 1 | 4 | _aDRUG RESISTANCE |
| 650 | 1 | 4 | _aGIARDIASIS |
| 650 | 1 | 4 | _aPROTOZOAN PARASITES |
| 700 | 1 | 2 | _aNoa Tejman-Yarden |
| 700 | 1 | 2 | _aLars Eckmann |
| 856 | 4 | 0 |
_uhttps://drive.google.com/file/d/1vmwKeRecvhKF6ZJ1dkZGcTUC55pTld55/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx |
| 942 |
_2Loc _cREF1 |
||
| 008 | 250602s9999 xx |||||s2 |||| ||und|d | ||
| 999 |
_c47820 _d47820 |
||